Photo by ang10ze from unsplash
In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is… Click to show full abstract
In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is that most patients present with advanced-stage disease, a time during which systemic therapies are unlikely to be curative.
Keywords:
identifying therapeutic;
vulnerabilities lung;
therapeutic vulnerabilities;
chemistry;
lung cancer
Journal Title: Translational lung cancer research
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Translational lung cancer research
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!